根据所用CAR-X检测试剂的类别,可提供的解决方案往往缺乏特异性,不易整合到流式检测组合中,或者仅用于检测单一CAR。 目前,常用Protein L、靶抗原、Tag标签抗体、ADA(抗抗体)、共表达GFP /tEGFR等去检测CAR表达情况,然而这些方法各有利弊,有些在实际检测中并不适用。 目前CAR检测手段利弊分析 Anti-(G4S)n (B02H...
GFP 绿色荧光蛋白(免疫组化用抗体) 规格: 0.1mlRabbit Anti-human sIgA/Gold 胶体金标记的兔抗分泌型IgA 规格: 0.5ml 酰芍药苷 订购|咨询 规格: 20mg HE琼脂 从其它肠道革兰氏阴性菌中分离沙门氏菌和志贺氏菌500g 7-O-基白杨 订购|咨询 规格: 20mg TFF2 三叶肽因子2抗体 规格: 0.1mlRabbit Anti-chicken...
Anti-TriCAR CAR-T细胞 耗竭模型 抑制信号逆转 产品编号产品名称规格目录价(元)货期 VGT-930-18C1Anti-CD19 hCAR-T细胞(scFv·CD3Z)1E7 细胞询价3～4周 VGT-930-18C2Anti-CD19 hCAR-GFP-T细胞(scFv·hCD28Z)1E7 细胞询价3～4周 VGT-930-18C3Anti-CD19 hCAR-GFP-T细胞(scFv·hCD2841BBZ)1E7 细胞询价...
抗体名:抗 GFP 纳米抗体 (SAA0921) 浓度:1 mg/ml % 靶点:GFP 宿主:XtenCHO expression 用途:仅用于科研 应用范围:一抗,中和抗体 纯度:0.95 % 产地:France 品牌:AntibodySystem 货号:RWK25802 用途:ELISA 亚型:VHH,Nanobody 是否单克隆:是 免疫原:N/A ...
文中表明,“经GFP mRNA优化后,用mRNA电穿孔的人T细胞转染效率为97%(图A)。用MgFP RNA载体对T细胞进行电穿孔,转染效率为79%(图A)。然后用流式细胞仪分析,用Fc特异性抗体检测编码抗EpCAM CAR的mRNA在人T细胞中的表达,表达量高达68.5%(图 B)。
Anti-PSCA CAR-T细胞 Anti-PSMA CAR-T细胞 Anti-TEM8 CAR-T细胞 Anti-TanCAR CAR-T细胞 Anti-TriCAR CAR-T细胞 耗竭模型 抑制信号逆转 产品编号产品名称规格目录价(元)货期 CD87scFv.SH.CD28.CD3ζ CMV-CD87scFv.CD8aHT.CD28.41BB. CD3ζ-EF1a-GFP ...
A human NK cell line (NK92) was transduced with lentiviruses expressing CAR and EGFP, and then CAR-EGFP-expressing NK92 (CAR-GFP NK92) cells were purified by flow cytometry basing on both CAR and EGFP expression (Fig. 1C). To investigate the potency and specific cytotoxicity of GPC3-...
根据所用CAR-X检测试剂的类别,可提供的解决方案往往缺乏特异性,不易整合到流式检测组合中,或者仅用于检测单一CAR。 目前,常用Protein L、靶抗原、Tag标签抗体、ADA(抗抗体)、共表达GFP /tEGFR等去检测CAR表达情况,然而这些方法各有利弊,有些在实际检测中并不适用。 2010 年,两名血癌患者成为宾夕法尼亚大学...
However, intratumoral CAR T-cell numbers diminish over time indicating insufficient persistence inside of the tumor microenvironment. Additional anti-VEGF-A/VEGF-R2 treatment results in reduced tumor growth after EpCAM/GFPCAR T-cell and GFPT-cell treatment, respectively. Interestingly, in vivo imaging...
Adoptive cell therapy (ACT) is a particularly promising area of cancer immunotherapy, engineered T and NK cells that express chimeric antigen receptors (CAR) are being explored for treating hematopoietic malignancies but exhibit limited clinical benefits